Trump names Heidi Overton to lead the FDA — and a Republican senator calls part of her record almost disqualifying on day one. We break down the confirmation fight, the regulatory risk to mRNA programs in oncology and immunology, Regeneron's Pasatru (garetosmab) approval for the ultra-rare bone disease fibrodysplasia ossificans progressiva, SK Biopharmaceuticals' Xcopri (cenobamate) patent settlement with MSN Laboratories, and SK Pharmteco's new high-potency API and ADC payload plants in Swords, Ireland. Visit us at thepharmacloseout.com.

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör BZ Group. Innehållet i podden är skapat av BZ Group och inte av, eller tillsammans med, Poddtoppen.